103
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Deep obturator lymph node dissection in gynaecological cancer patients: Is it feasible and useful?

, , , &
Pages 812-816 | Received 15 Feb 2015, Accepted 13 Feb 2016, Published online: 09 May 2016

References

  • Aletti GD, Dowdy S, Podratz KC, Cliby WA. 2006. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. American Journal of Obstetrics and Gynecology 195:1862–1868.
  • Armstrong EP. 2010. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. Journal of Managed Care Pharmacy 16:217–230.
  • Carnino F, Fuda G, Ciccone G, Iskra L, Guercio E, Dadone D, et al. 1997. Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecologic Oncology 65:467–472.
  • 1987. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics. American Journal of Obstetrics and Gynecology 156:263–264.
  • Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. 2005. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. Journal of Clinical Oncology 23:3668–3675.
  • di Re F, Baiocchi G, Fontanelli R, Grosso G, Cobellis L, Raspagliesi F, et al. 1996. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecologic Oncology 62:360–365.
  • Downey GO, Potish RA, Adcock LL, Prem KA, Twiggs LB. 1989. Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection. American Journal of Obstetrics and Gynecology 160:1055–1061.
  • Finan MA, De Cesare S, Fiorica JV, Chambers R, Hoffman MS, Kline RC, et al. 1996. Radical hysterectomy for stage Ib1 vs. Ib2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecologic Oncology 62:138–147.
  • Hacker NF. 1995. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer-therapeutic advance or surgical folly? Gynecologic Oncology 56:325–327.
  • Hacker NF, Wain GV, Nicklin JL. 1995. Resection of bulky positive lymph nodes in patients with cervical carcinoma. International Journal of Gynecological Cancer 5:250–256.
  • Hosaka M, Watari H, Mitamura T, Konno Y, Odagiri T, Kato T, et al. 2011. Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. International Journal of Clinical Oncology 16:33–38.
  • Huang H, Liu J, Li Y, Wan T, Feng Y, Li Z, Huang Q. 2011. Metastasis to deep obturator and para-aortic lymph nodes in 649 patients with cervical carcinoma. European Journal of Surgical Oncology 37:978–983.
  • Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. 2005. Cancer statistics, 2005. CA: A Cancer Journal for Clinicians 55:10–30.
  • Kadkhodayan S, Shiravani Z, Hasanzadeh M, Sharifi N, Yousefi Z, Fattahi A, et al. 2014. Lymphatic mapping and sentinel node biopsy in endometrial cancer – a feasibility study using cervical injection of radiotracer and blue dye. Nuclear Medicine Review. Central & Eastern Europe 17:55–58.
  • Kenter GG, Hellebrekers BW, Zwinderman KH, van de Vijver M, Peters LA, Trimbos JB. 2000. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma. Acta Obstetricia et Gynecologica Scandinavica 79:72–76.
  • Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, et al. 2014. Utreine neoplasms, version 1.2014. Journal of the National Comprehensive Cancer Network 12:248–280.
  • Kidd EA, El Naqa I, Siegel BA, Dehdashti F, Grigsby PW. 2012. FDG-PET-based prognostic nomograms for locally advanced cervical cancer. Gynecologic Oncology 127:136–140.
  • Kjørstad KE. 1988. The rationale of pelvic lymphadenectomy in patients with stage Ib cancer of the cervix: a diagnostic or therapeutic procedure? Baillière’s Clinical Obstetrics and Gynaecology 2:905–911.
  • Mahawerawat S, Charoenkwan K, Srisomboon J, Khunamornpong S, Suprasert P, Sae-Teng CT. 2013. Surgical outcomes of patients with Stage IA2 cervical cancer treated with radical hysterectomy. Asian Pacific Journal of Cancer Prevention 14:5375–5378.
  • Manchana T, Sirisabya N, Lertkhachonsuk R, Worasethin P, Khemapech N, Sittisomwong T, et al. 2009. Long term complications after radical hysterectomy with pelvic lymphadenectomy. J Med Assoc Thai of Medical of 92:451–456.
  • Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, et al. 2006. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecologic Oncology 101:200–208.
  • Marnitz S, Köhler C, Bongardt S, Braig U, Hertel H, Schneider A, German Association of Gynecologic Oncologists (AGO). 2006. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecologic Oncology 103:35–44.
  • Mayer AR, Chambers SK, Graves E, Holm C, Tseng PC, Nelson BE, et al. 1992. Ovarian cancer staging: does it require a gynecologic oncologist? Gynecologic Oncology 47:223–227.
  • Orr JW Jr, Holimon JL, Orr PF. 1997. Stage I corpus cancer: is teletherapy necessary? American Journal of Obstetrics and Gynecology 176:777–788.
  • Ozols RF. 2003. Maintenance therapy in advanced ovarian cancer: progression-free survival and clinical benefit. Journal of Clinical Oncology 21:2451–2453.
  • Panici PB, Scambia G, Baiocchi G, Matonti G, Capelli A, Mancuso S. 1992. Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies. Obstetrics and Gynecology 79:498–502.
  • Patsner B, Sedlacek TV, Lovecchio JL. 1992. Para-aortic node sampling in small (3-cm or less) stage IB invasive cervical cancer. Gynecologic Oncology 44:53–54.
  • Pieterse QD, Kenter GG, Gaarenstroom KN, Peters AA, Willems SM, Fleuren GJ, et al. 2007. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. European Journal of Surgical Oncology (the Journal of Cancer Surgery) 33:216–221.
  • Piura B, Rabinovich A, Friger M. 2006. Number and distribution of pelvic lymph nodes and effect of surgical pathologic factors on pelvic lymph node status in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection. European Journal of Gynaecological Oncology 27:463–466.
  • Rahatli S, Dizdar O, Kucukoztas N, Oguz A, Yalcin S, Ozen O, et al. 2014. Good outcomes of patients with stage IB endometrial cancer with surgery Alone. Asian Pacific Journal of Cancer Prevention 15:3891–3893.
  • Rai B, Bansal A, Patel FD, Sharma SC. 2014. Radiotherapy for ovarian cancers – redefining the role. Asian Pacific Journal of Cancer Prevention 15:4759–4763.
  • Sakuragi N. 2007. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. International Journal of Clinical Oncology 12:165–175.
  • Serov SF, Soully RF, Sobin LH. 1973. Histological typing of ovarian tumors. International histological classification of tumors. Geneva: World Health Organization. p. 37–42.
  • Straughn JM, Huh WK, Orr JW Jr, Kelly FJ, Roland PY, Gold MA, et al. 2003. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecologic Oncology 89:295–300.
  • Trimbos JB, Hellebrekers BW, Kenter GG, Peters LA, Zwinderman KH, et al. 2000. The long learning curve of gynaecological cancer surgery: an argument for centralisation. BJOG: An International Journal of Obstetrics & Gynaecology 107:19–23.
  • Verleye L, Vergote I, Reed N, Ottevanger PB. 2009. Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer–Gynecological Cancer Group (EORTC-GCG). Annals of Oncology 20:1631–1638.
  • Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Torri V, et al. 1998. The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis. Annals of Oncology 9:1097–1101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.